Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Patent
1993-08-02
1997-02-04
Henley, III, Raymond
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
514565, 514634, A61K 3119, A61K 31195, A61K 31155
Patent
active
055998410
ABSTRACT:
The present invention provides a method for treating or preventing certain metabolic disorders comprising the systemic administration of 3-guanidinopropionic acid.
REFERENCES:
patent: 3843798 (1974-10-01), Cook
A. Aynsley-Green and K. G. M. M. Alberti, "In Vivo Stimulation of Insulin Secretion by Guanidine Derivatives in the Rat", Horm. Metab. Res. 6:115-120 (1974).
F. Blachier, et al., "Stimulus-Secretion Coupling of Arginine-Induced Insulin Release. Uptake of Metabolized and Nonmetabolized Cationic Amino Acids by Pancreatic Islets", Endocrinology 124(1):134-141 (1989).
J. J. Roberts and J. B. Walker, "Feeding a Creatine Analogue Delays ATP Depletion and Onset of Rigor in Ischemic Heart", Am. J. Physiol. 243:H911-H916 (1982).
T. S. Moerland, et al., "Administration of a Creative Analogue Induces Isomyosin Transitions in Muscle", Am. J. Physiol. 257:C810-C816 (1989).
E. A. Shoubridge, et al., "Biochemical Adaptation in the Skeletal Muscle of Rats Depleted of Creatine with the Substrate Analogue .beta.-Guanidinopropionic Acid", Biochem. J. 232:125-131 (1985).
D. A. MaHanna, et al., "Effects of .beta.-Guanidinopropionic Acid on Murine Skeletal Muscle", Exper. Neurol. 68:114-121 (1980).
R. P. Shields, et al., "Skeletal Muscle Function and Structure After Depletion of Creatine", Lab. Invest. 33(2):151-158 (1975.
J. V. Otten, et al., "Thyrotoxic Myopathy in Mice: Accentuation by a Cratine Transport Inhibitor", Metabolism 35(6):481-484 (1986).
D. S. Grosso, et al., "Characterization of a Carrier-Medicated Transport System for Taurine in the Feta Mouse Heart In Vitro", J. Clin. Invest., E61(4):944-952 (1978).
Henley III Raymond
The Upjohn Company
Weddington Kevin
Welch Lawrence T.
LandOfFree
Use of 3-guanidinopropionic acid in the treatment and prevention does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of 3-guanidinopropionic acid in the treatment and prevention, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of 3-guanidinopropionic acid in the treatment and prevention will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-679081